Texas A&M Health Science Center College of Medicine.
Clinical Services Group, Hospital Corporation of America (HCA), Houston, Texas.
Clin Infect Dis. 2017 Oct 16;65(9):1565-1569. doi: 10.1093/cid/cix603.
The Center for Medicare and Medicaid Services adopted the Early Management Bundle, Severe Sepsis/Septic Shock (SEP-1) performance measure to the Hospital Inpatient Quality Reporting Program in July 2015 to help address the high mortality and high cost associated with sepsis. The SEP-1 performance measure requires, among other critical interventions, timely administration of antibiotics to patients with sepsis or septic shock. The multistakeholder workgroup recognizes the need for SEP-1 but strongly believes that multiple antibiotics listed in the antibiotic tables for SEP-1 are not appropriate and the use of these antibiotics, as called for in the SEP-1 measure, is not in alignment with prudent antimicrobial stewardship. To promote the appropriate use of antimicrobials and combat antimicrobial resistance, the workgroup provides recommendations for appropriate antibiotics for the treatment of sepsis.
医疗保险和医疗补助服务中心于 2015 年 7 月通过了早期管理捆绑包，严重脓毒症/败血症休克（SEP-1）绩效措施纳入医院住院质量报告计划，以帮助解决与败血症相关的高死亡率和高成本问题。SEP-1 绩效措施除其他关键干预措施外，还要求对脓毒症或败血症休克患者及时给予抗生素。多利益攸关方工作组认识到 SEP-1 的必要性，但强烈认为 SEP-1 抗生素表中列出的多种抗生素不合适，并且按照 SEP-1 措施的要求使用这些抗生素不符合审慎使用抗菌药物的原则。为了促进抗生素的合理使用和对抗抗生素耐药性，工作组为治疗败血症提供了合适抗生素的建议。
